Press Release & Community Statement: Lexeo Therapeutics Announces Publication in JAMA Cardiology of Phase I/II Data for LX2006 in Friedreich Ataxia
Industry News
News|Jun 15 2026
Press Release: Update from Lexeo Therapeutics
Industry News
Blog|Jun 8 2026
Meet The Community: Deborah Medford
Community
News|Jun 4 2026
May/June 2026 – Advocacy Newsletter
Advocacy
News|Jun 1 2026
Webinar Recording: Solid Biosciences May 2026
FARA News | Industry News
Blog|Jun 1 2026
Meet The Community: Kadence Foley
Community
News|May 29 2026
Community Letter: Update from PTC Therapeutics
Industry News
Blog|May 25 2026
Meet The Community: Carly Stinson
Community
News|May 22 2026
Recordings Available: FARA Flash Talks 2026
Recordings are now available for the 2026 FARA Flash Talks! If you were unable to watch this year's Flash Talks live, please view the se...
Education
News|May 18 2026
Design Therapeutics Announces Four-Week IV Data from the RESTORE-FA Trial of DT-216P2 Demonstrating Clinical Improvements and Comprehensive Biomarker Activity in FA